Skip to main content

Holiday schedule

Our Patient Service Centers will be closed on Monday, May 27, 2024 for the Memorial Day holiday. Have a healthy, happy holiday.

Hide

Know the early warning signs of metabolic syndrome—a growing problem

Patients who have metabolic syndrome are at higher risk of multiple chronic conditions, including diabetes, coronary heart disease, cancer, and stroke. Metabolic syndrome has become increasingly common: its prevalence has risen in every sociodemographic group, and today it is estimated that more than a third of adults in the United States have metabolic risk.1

Some factors contributing to metabolic syndrome are genetic, while others can be modified with lifestyle changes. Quest Diagnostics offers a full range of testing options to help evaluate patients’ metabolic and cardiovascular risk, so physicians can take action to help prevent or delay onset of chronic conditions, and prevent adverse events such as stroke.

Metabolic testing from Quest Diagnostics

Quest offers a full complement of tests, from routine to advanced, to help you obtain the most complete picture possible of your patient’s risk of metabolic syndrome.

Metabolic tests

Diabetes tests

Complementary vitamin and supplement tests

Get the early warning signs. Learn more about our metabolic testing and more.

Identify the risk of metabolic syndrome

Quest offers a full complement of tests, from routine to advanced, to help you obtain the most complete picture possible of your patient’s risk of metabolic syndrome.

Learn More

This information is provided for informational purposes only and is not intended as medical advice. A physician’s test selection and interpretation, diagnosis, and patient management decisions should be based on his/her education, clinical expertise, and assessment of the patient.

 

References

  1. Moore JX, Chaudhary N, Akinyemiju T. Metabolic syndrome prevalence by race/ethnicity and sex in the United States, National Health and Nutrition Examination Survey, 1988–2012. Prev Chronic Dis. 2017;14:e24. doi:10.5888/pcd14.160287